Stock Analysis

Is It Time To Consider Buying Precise Biometrics AB (publ) (STO:PREC)?

OM:PREC
Source: Shutterstock

While Precise Biometrics AB (publ) (STO:PREC) might not be the most widely known stock at the moment, it saw significant share price movement during recent months on the OM, rising to highs of kr1.80 and falling to the lows of kr1.07. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Precise Biometrics' current trading price of kr1.07 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Precise Biometrics’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

Check out our latest analysis for Precise Biometrics

What's The Opportunity In Precise Biometrics?

The stock seems fairly valued at the moment according to my valuation model. It’s trading around 16.72% above my intrinsic value, which means if you buy Precise Biometrics today, you’d be paying a relatively reasonable price for it. And if you believe the company’s true value is SEK0.92, there’s only an insignificant downside when the price falls to its real value. Is there another opportunity to buy low in the future? Since Precise Biometrics’s share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What does the future of Precise Biometrics look like?

earnings-and-revenue-growth
OM:PREC Earnings and Revenue Growth August 30th 2023

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Precise Biometrics' earnings over the next few years are expected to increase by 75%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? PREC’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping tabs on PREC, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. Be aware that Precise Biometrics is showing 4 warning signs in our investment analysis and 2 of those are significant...

If you are no longer interested in Precise Biometrics, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Valuation is complex, but we're helping make it simple.

Find out whether Precise Biometrics is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.